Kisunla
Payments companies reported to CMS as associated with Kisunla. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Kisunla, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Kisunla
These are the largest totals companies reported as associated with Kisunla. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ronald Schwartz | Hattiesburg, MS | Neurology (Psychiatry & Neurology) | $185,484.68 |
| Paul Schulz | Houston, TX | Behavioral Neurology & Neuropsychiatry | $173,551.69 |
| David Bear | Pensacola, FL | Neurology (Psychiatry & Neurology) | $156,783.93 |
| Andrew Budson | Boston, MA | Neurology (Psychiatry & Neurology) | $150,313.82 |
| Armen Moughamian | San Francisco, CA | Neurology (Psychiatry & Neurology) | $149,599.36 |
| Peter Mcallister | Fairfield, CT | Neurology (Psychiatry & Neurology) | $132,421.21 |
| Ira Goodman | Orlando, FL | Neurological Surgery | $108,654.83 |
| Waleed El-Feky | Dallas, TX | Neurology (Psychiatry & Neurology) | $107,144.17 |
| Joel Salinas | New York, NY | Neurology (Psychiatry & Neurology) | $102,848.12 |
| Nida Laurin | Scottsdale, AZ | Neurology (Psychiatry & Neurology) | $101,821.11 |
Prescribed Kisunla?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.